Company executives said clinical trials will be carried out on asymptomatic and suspected patients of Covid-19 to test the efficacy of immunity boosters in preventing and curing the patients. The trial results are expected to be released in about two months.from Industry-Economic Times
Read The Rest:economictimes...
